<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>09001570549037</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015793</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.175Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549051</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015794</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.165Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549075</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015795</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.149Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549099</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015796</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549136</udiDi>
    <basicUdiDi>9001570NOF-032VB-N-347</basicUdiDi>
    <tradeName>sempermed skySense VB (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015821</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.108Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549150</udiDi>
    <basicUdiDi>9001570NOF-032VB-N-347</basicUdiDi>
    <tradeName>sempermed skySense VB (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015822</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.093Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549174</udiDi>
    <basicUdiDi>9001570NOF-032VB-N-347</basicUdiDi>
    <tradeName>sempermed skySense VB (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015823</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.081Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549198</udiDi>
    <basicUdiDi>9001570NOF-032VB-N-347</basicUdiDi>
    <tradeName>sempermed skySense VB (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015824</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.061Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549211</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>semperguard skySense</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015827</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.047Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549235</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>semperguard skySense</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015828</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.036Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549259</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>semperguard skySense</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015829</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549273</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>semperguard skySense</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015830</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:45.010Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549297</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>semperguard skySense</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015831</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.994Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549402</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015946</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.979Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549426</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015947</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.961Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549440</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015948</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.949Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549464</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015949</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.935Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549488</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015950</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549754</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015965</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.908Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549778</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015966</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.896Z</lastUpdated>
  </row>
</eudamedExport>